JMP Securities analyst Roy Buchanan reiterated a Buy rating on Inovio Pharmaceuticals (INO – Research Report) today and set a price target of $18.00. Discover outperforming stocks and invest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback